openPR Logo
Press release

Embolotherapy market size to reach USD 6168.7 million by 2029 with a CAGR of 6.7% during 2023-2029

04-15-2024 03:42 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Quants and Trends

Embolotherapy market

Embolotherapy market

The global Embolotherapy market size was valued at USD 3918 million in 2022 and is forecast to a readjusted size of USD 6168.7 million by 2029 with a CAGR of 6.7% during review period. The global embolotherapy market is experiencing significant growth, driven by advancements in healthcare technologies, increasing prevalence of chronic diseases, and rising demand for minimally invasive procedures. Embolotherapy, a therapeutic approach aimed at occluding blood vessels, has witnessed a surge in adoption owing to its efficacy in treating various medical conditions.

Market Overview:
Embolotherapy involves the deliberate occlusion of blood vessels for therapeutic purposes. It is widely utilized in the treatment of tumors, vascular malformations, aneurysms, and other conditions. The market encompasses a wide array of embolic agents, delivery systems, and imaging modalities tailored to meet the diverse needs of healthcare providers and patients.
Global top 3 companies hold a share over 30%. North America is the largest market, with a share about 35%, followed by Europe and China with the share about 25% and 20%. In terms of product, Microspheres for Embolization is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer, with a share about 50%.

Market Key Players:
• Medtronic
• Boston Scientific
• Terumo
• Penumbra, Inc.
• Johnson & Johnson
• Sirtex
• Merit Medical
• Varian
• Stryker
• Jiangsu Hengrui Pharmaceuticals Co., Ltd
• Cook Medical
• Kaneka
• Meril Life Sciences
• Peijia Medical Limited
• Wallaby Medical
• MicroPort Scientific Corporation
• Shandong Visee Medical Devices Co.,Ltd
• Beijing Taijie Weiye Technology

GET FREE SAMPLE REPORT PDF @ https://quantsandtrends.com/form/request-for-free-sample-pdf?report_code=HC1740&nid=1377

Market Segmentation by Type:
• Microspheres for Embolization
• Embolism Particles
• Embolic coils
• Liquid Embolic Agent
• Auxiliary Embolization Material
• Others

Market Segmentation by Application:
• Cancer
• Peripheral Aascular Disease
• Nerve System Disease
• Others

US Market:
The United States represents a significant market for embolotherapy, driven by the presence of well-established healthcare infrastructure, increasing prevalence of chronic diseases, and favorable reimbursement policies.

EUROPE Market:
Europe is witnessing a steady growth in the embolotherapy market, fueled by advancements in medical technology, rising healthcare expenditure, and growing awareness about minimally invasive procedures.

APAC Market:
The Asia-Pacific region is emerging as a lucrative market for embolotherapy, supported by rapid urbanization, improving healthcare facilities, and a growing patient population.

Middle-East Market:
The Middle-East embolotherapy market is experiencing notable growth, attributed to the increasing incidence of cardiovascular diseases, rising healthcare investments, and expanding medical tourism sector.

Market Segmentation by Regions:
• North America (United States, Canada, and Mexico)
• Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
• South America (Brazil, Argentina and Rest of South America)
• Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

For Exhaustive Table of Contents and Tables and Figures, please visit @ https://quantsandtrends.com/Embolotherapy-Market

Market Strengths:
• Minimally invasive nature of embolotherapy procedures
• Growing adoption of advanced embolic agents
• Increasing prevalence of chronic diseases
• Favorable reimbursement policies

Market Weaknesses:
• High cost associated with embolotherapy procedures
• Limited awareness among healthcare professionals and patients
• Stringent regulatory approvals for new embolic agents

Market Opportunities:
• Untapped potential in emerging markets
• Technological advancements in imaging modalities
• Rising demand for targeted drug delivery systems

Market Threats:
• Intense competition among key players
• Potential risks associated with embolization procedures
• Regulatory challenges in different regions

Market Past Performance:
The embolotherapy market has witnessed steady growth in recent years, driven by increasing adoption of minimally invasive procedures and advancements in embolic agents. However, challenges such as regulatory hurdles and high treatment costs have restrained market expansion to some extent.

Market Forecast:
The global embolotherapy market is projected to grow at a robust rate over the forecast period, driven by growing demand for minimally invasive treatments, technological advancements, and expanding applications in various medical specialties.

Market Research and Development:
Ongoing research and development activities are focused on developing novel embolic agents, enhancing delivery systems, and improving imaging techniques to optimize treatment outcomes and minimize complications associated with embolotherapy procedures.

Market Pestel Analysis:
• Political: Regulatory frameworks influence market entry and product approvals.
• Economic: Healthcare expenditure and reimbursement policies impact market growth.
• Social: Increasing awareness about minimally invasive procedures drives market demand.
• Technological: Advancements in imaging technologies and embolic agents fuel market innovation.
• Environmental: Environmental regulations may affect manufacturing processes and product disposal.
• Legal: Stringent regulations govern the approval and marketing of embolotherapy products.

Market Sipoc Analysis:
• Suppliers: Manufacturers of embolic agents, medical devices, and imaging equipment.
• Inputs: Raw materials, research & development, regulatory approvals.
• Processes: Production, distribution, clinical trials, regulatory compliance.
• Outputs: Embolotherapy products, treatment outcomes, patient satisfaction.
• Customers: Healthcare providers, hospitals, patients.

Conclusion:
The embolotherapy market presents significant opportunities for growth and innovation, driven by increasing demand for minimally invasive procedures, technological advancements, and expanding applications across various medical specialties. Key players are focusing on research and development initiatives to introduce novel products and gain a competitive edge in the market. With favorable market dynamics and evolving healthcare landscapes, the embolotherapy market is poised for sustained expansion in the coming years.

For further inquiries, please contact:
info@quantsandtrends.com
US: +1-315-675-4303
INDIA: +91-952-980-3362
Sector-13, Chikhali Pradhikaran,
Pune-411019, Maharashtra, India.
https://quantsandtrends.com/

About Quants and Trends:
Through our consulting research solutions, we guide our clients in discovering answers to their research needs. We pledge to offer our clients only the best research and consulting services. With our low-cost market research services, we assist our clients in understanding the major industry trends, spotting opportunities, and coming to wise conclusions. We understand not every client's particular research needs may be satisfied by syndicated papers. We offer our dear clients with an array of options to tailor research to meet their unique objectives and financial constraints.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Embolotherapy market size to reach USD 6168.7 million by 2029 with a CAGR of 6.7% during 2023-2029 here

News-ID: 3464463 • Views:

More Releases from Quants and Trends

Shape Memory Alloys Market Size Worth USD 1385.4 Million by 2029 at a CAGR of 8.2% during review period 2023-2029
Shape Memory Alloys Market Size Worth USD 1385.4 Million by 2029 at a CAGR of 8. …
The global Shape Memory Alloys Market size was valued at USD 796.4 million in 2022 and is forecast to a readjusted size of USD 1385.4 million by 2029 with a CAGR of 8.2% during review period. Market Overview: Shape Memory Alloys (SMAs) are revolutionary materials with the unique ability to return to a predetermined shape when subjected to certain stimuli, such as temperature or stress. This remarkable property has led to their
Electroless Plating Market Worth USD 5469.7 Million by 2029 at a CAGR of 3.0% during review period 2023-2029
Electroless Plating Market Worth USD 5469.7 Million by 2029 at a CAGR of 3.0% du …
The global Electroless Plating Market size was valued at USD 4457.4 million in 2022 and is forecast to a readjusted size of USD 5469.7 million by 2029 with a CAGR of 3.0% during review period. Market Overview: Electroless plating, also known as autocatalytic plating, is a chemical process that deposits a metal or alloy onto a substrate without the use of an external electrical power source. This method offers several advantages, including
Braze Market Size Worth USD 5563.3 Million by 2029 at a CAGR of 1.8% during review period 2023-2029
Braze Market Size Worth USD 5563.3 Million by 2029 at a CAGR of 1.8% during revi …
The global Braze Market size was valued at USD 4904 million in 2022 and is forecast to a readjusted size of USD 5563.3 million by 2029 with a CAGR of 1.8% during review period. Market Overview: The Braze Market plays a pivotal role in various industries, offering a reliable method for joining metal components with superior strength and durability. Brazing involves the use of a filler metal that melts above 450°C (840°F)
Re-dispersible Latex Powder (RDP) Market Worth USD 1935.3 Million by 2029 at a CAGR of 3.2% during review period 2023-2029
Re-dispersible Latex Powder (RDP) Market Worth USD 1935.3 Million by 2029 at a C …
The global Re-dispersible Latex Powder (RDP) Market size was valued at USD 1556.8 million in 2022 and is forecast to a readjusted size of USD 1935.3 million by 2029 with a CAGR of 3.2% during review period. Market Overview: Re-dispersible latex powder (RDP) is a crucial additive used in construction materials such as mortars, plasters, and tile adhesives. It enhances the performance of these materials by imparting properties such as improved adhesion,

All 5 Releases


More Releases for Embolotherapy

Embolotherapy Market is expected to reach USD 7.7 billion by 2031
According to a new market research report published by Global Insight Services " Embolotherapy Market is expected to reach USD 7.7 billion by 2031. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market. Access Full Report
Embolotherapy Market 2022 Latest Innovative Research Report Driving Astonishing …
The Embolotherapy Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well. The report makes inclusion of vital information such as market size, growth rate, and valuation
Embolotherapy Market 2022 - 2028 Worldwide Major Industry Players' Review
The "Global Embolotherapy Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of Embolotherapy Market with detailed market segmentation by type, application, end user and geography. The global Embolotherapy Market is expected to witness high growth during the forecast period. The report provides key statistics on the
Embolotherapy Market 2022- Key Strategy, Revenue, Opportunity, Business Segment …
The Embolotherapy Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well. The report makes inclusion of vital information such as market size, growth rate, and valuation
Embolotherapy Market To Generate $6,447.1 Million Revenue by 2030
A number of factors, such as the rising incidence of lifestyle-associated and chronic illnesses, growing aging population, surging patient pool, increasing healthcare spending, growing medical tourism industry, and enhancing healthcare infrastructure, are projected to propel the growth of the embolotherapy market at CAGR of 7.7% during the forecast period (2020–2030). According to P&S Intelligence, the market size is expected to reach $6,447.1 million by 2030 from $3,082.9 million in 2020.
Global Embolotherapy Market expected to boost with escalating development opport …
The latest report put out by Zion Market Research on the global Embolotherapy Market offers an in-depth analysis of prominent players, key market drivers, global revenue, market segments, and their sub-segments. The market study also involves major geographic regions and revenue forecasts for the regions as well as their countries. The report assesses the market size in terms of value for the forecast period of 2020-2026. According to the Report